Published in Perit Dial Int on January 01, 1989
Disinfection of CAPD solution bag medication ports. Perit Dial Int (1992) 0.75
Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int (2001) 2.81
Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int (1997) 2.47
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Who provides patients with drug information? Br Med J (Clin Res Ed) (1987) 2.04
Do diabetic patients inject accurate doses of insulin? Diabetes Care (1981) 2.02
Principles for the management of penetrating cardiac wounds. Ann Surg (1979) 1.69
Accuracy of penicillin allergy reporting. Am J Hosp Pharm (1994) 1.64
Nonnarcotic analgesics: prevalence and estimated economic impact of toxicities. Ann Pharmacother (1997) 1.53
Concurrent administration of ciprofloxacin and potentially interacting drugs. Am J Hosp Pharm (1989) 1.51
Disruptions in drug therapy in long-term dialysis patients who require hospitalization. Am J Health Syst Pharm (1999) 1.48
Pharmacokinetics of once-daily IP gentamicin in CAPD patients. Perit Dial Int (1997) 1.47
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol (1989) 1.28
In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule. Tuber Lung Dis (1992) 1.20
Antiretroviral prescribing errors in hospitalized patients. Ann Pharmacother (2001) 1.16
Absorption interactions with fluoroquinolones. 1995 update. Drug Saf (1995) 1.12
Gentamicin dosing errors with four commonly used nomograms. JAMA (1982) 1.11
Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997). J Clin Microbiol (1999) 1.09
Comparison of three isolation systems for the culture of mycobacteria from respiratory and non-respiratory samples. J Clin Pathol (2000) 1.06
Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol (1997) 1.05
Vancomycin, red neck syndrome, and fits. Lancet (1985) 0.99
Errors in prescribing methotrexate. JAMA (1992) 0.96
Antimicrobial drug delivery to the eye. Drug Intell Clin Pharm (1985) 0.96
Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol (1992) 0.92
Systematic review of tattoo-associated skin infection with rapidly growing mycobacteria and public health investigation of a cluster in Scotland, 2010. Euro Surveill (2013) 0.92
Isolation of Mycobacterium malmoense from HIV-positive patients. J Infect (1993) 0.90
Successful treatment of CAPD peritonitis caused by Neisseria cinerea. Perit Dial Int (1994) 0.90
Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study. J Hepatol (1994) 0.90
Detection of hepatitis "C" virus in formalin-fixed liver tissue by nested polymerase chain reaction. J Med Virol (1992) 0.89
Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services. J Clin Pharm Ther (1987) 0.89
Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis? Nephron (1987) 0.88
Knowledge of hemodialysis and CAPD patients about their prescribed medicines. Clin Nephrol (1990) 0.87
Effect of staggered dose of calcium on the bioavailability of ciprofloxacin. Antimicrob Agents Chemother (1991) 0.87
Risk factors for inadequate use of pressurized aerosol inhalers. J Clin Pharm Ther (1988) 0.87
Quinolone-cation interactions: a review. DICP (1991) 0.87
Comparative activity of azithromycin against clinical isolates of mycobacteria. J Antimicrob Chemother (1996) 0.87
Intermittent intravenous piperacillin pharmacokinetics in automated peritoneal dialysis patients. Perit Dial Int (2001) 0.87
Comparing medication use in two hemodialysis units against national dialysis databases. Am J Health Syst Pharm (2000) 0.87
Common prescribing errors. Ann Intern Med (1992) 0.86
Successful treatment of Aeromonas hydrophila peritoneal dialysis-associated peritonitis using intermittent intraperitoneal gentamicin. Clin Nephrol (1995) 0.86
Intravenous iron products. ANNA J (1999) 0.86
Non-tuberculous mycobacteria in a hospital's piped water supply. J Hosp Infect (1992) 0.85
Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis. J Am Soc Nephrol (2000) 0.85
Cerebrovascular accident after vacuum-assisted venous drainage in a Fontan patient: a cautionary tale. Ann Thorac Surg (2001) 0.85
Pharmacokinetics of intermittent intraperitoneal ceftazidime. Am J Kidney Dis (1999) 0.84
Pharmacists' perceptions of alternative health approaches--a comparison between U.S. and British pharmacists. J Clin Pharm Ther (1990) 0.84
Stability of iron dextran (DexFerrum) in peritoneal dialysis bags. Perit Dial Int (1999) 0.84
Dosing adjustment of 10 antimicrobials for patients with renal impairment. Ann Pharmacother (1995) 0.84
Stability of amphotericin B-lipid complex (Abelcet) in peritoneal dialysis solutions. Perit Dial Int (2000) 0.83
Lindane (Kwell)-induced aplastic anemia. Arch Intern Med (1990) 0.83
Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients. Int J Artif Organs (2005) 0.83
Comparison of programs for preventing drug-nutrient interactions in hospitalized patients. Am J Health Syst Pharm (1997) 0.83
Cyclosporine-associated arthralgia. Clin Nephrol (1990) 0.83
Streamlining antimicrobial therapy through pharmacists' review of order sheets. Am J Hosp Pharm (1989) 0.82
Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic technique. Antimicrob Agents Chemother (1982) 0.82
Massive and extended rebound of serum lithium concentrations following hemodialysis in two chronic overdose cases. Am J Emerg Med (1998) 0.82
Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics. Perit Dial Int (2001) 0.81
Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers. Am J Kidney Dis (2001) 0.81
Pharmacokinetics of ciprofloxacin in subjects with varying degrees of renal function and undergoing hemodialysis or CAPD. Clin Nephrol (1993) 0.81
Unsuccessful treatment of CAPD peritonitis caused by Alcaligenes xylosoxidans subsp. denitrificans. Ren Fail (1995) 0.81
Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients. Perit Dial Int (2001) 0.80
Pentamidine-associated nephrotoxicity and hyperkalemia in patients with AIDS. DICP (1991) 0.79
Red-neck syndrome associated with intraperitoneal vancomycin. Clin Pharm (1990) 0.79
Aminoglycoside therapy. Improving patient response and safety. Postgrad Med (1984) 0.79
Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity. Nephrol Dial Transplant (1996) 0.79
Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure. Hepatology (1996) 0.79
Pleurodesis with solution prepared from quinacrine hydrochloride tablets. Clin Pharm (1993) 0.79
Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection. Invest Ophthalmol Vis Sci (1986) 0.78
Familial ichthyosis, dwarfism, mental retardation, and renal disease. J Pediatr (1978) 0.78
Lithium therapy. Careful workup, close follow-up to avoid toxicity. Postgrad Med (1984) 0.77
Bioavailability of bumetanide in grossly oedematous patients. Clin Pharmacokinet (1987) 0.77
Epoetin in the 'untransfusable' anaemic patient: a retrospective case series and systematic analysis of literature case reports. Transfus Med (2014) 0.77
Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int (1999) 0.77
Preventing medication prescribing errors. DICP (1991) 0.77
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis. Clin Pharmacokinet (1990) 0.77
Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas. J Immunother (1991) (1991) 0.77
Intraperitoneal antibiotics effectively treat non-dialysis-related infections. Perit Dial Int (1995) 0.77
Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics. Perit Dial Int (2001) 0.76
Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup. Kidney Int (1999) 0.76
Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin. Ann Pharmacother (1993) 0.76
Treatment of acute carbamazepine poisoning by hemoperfusion. Am J Emerg Med (1996) 0.76
Second-generation antibiotic-order sheet. Am J Hosp Pharm (1986) 0.76
Occult HBV in NANB fulminant hepatitis. Lancet (1993) 0.75
Exfoliative reaction to vancomycin. Br Med J (Clin Res Ed) (1988) 0.75
Hyperammonemic encephalopathy during hemodialysis. Ann Intern Med (1983) 0.75
Plasma growth hormone (GH) responses to growth hormone releasing factor (hp GRF 1-44) in familial GH deficiency. Acta Paediatr Scand (1987) 0.75
Imipenem/cilastatin efficacy evaluated. Drug Intell Clin Pharm (1985) 0.75
Comment: pharmacy manpower contrast--U.K. Drug Intell Clin Pharm (1986) 0.75
Surreptitious use of antimicrobial agents by CAPD patients. Perit Dial Int (1993) 0.75
Relationship between peritonitis and exit site infections in CAPD. Adv Perit Dial (1992) 0.75
Unusual treatment response of a severe dystonia to diphenhydramine. Ann Emerg Med (1987) 0.75
Chemical peritonitis associated with intraperitoneal vancomycin. DICP (1991) 0.75
Turbid dialysate effluent and bacterial peritonitis. Clin Nephrol (1991) 0.75
Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration. Perit Dial Int (1992) 0.75
Renal transplant patients' knowledge concerning cyclosporine treatment. Clin Nephrol (1991) 0.75
Timeliness of medication administration in hemodialysis inpatients: drug use evaluation. Hosp Pharm (1993) 0.75
Stability of erythromycin lactobionate in peritoneal dialysate solutions. Perit Dial Int (1994) 0.75
Acute renal failure and hyperkalemia associated with triamterene and indomethacin. Vet Hum Toxicol (1986) 0.75
Possible ganciclovir-induced hepatotoxicity in patients with AIDS. Clin Pharm (1992) 0.75
Cost-effectiveness of gentamicin vs tobramycin. Pharmacoeconomics (1993) 0.75